Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

VR games aim to reboot attention in brain injury patients

NCT ID NCT05728840

Symptom relief Sponsor: Mindmaze SA Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether virtual reality exercises can improve attention problems in people who have had a brain injury, like a stroke or traumatic brain injury. About 135 participants will either do VR-based cognitive games or standard pen-and-paper exercises for 20 sessions. The goal is to see if the VR approach is more effective at boosting attention and focus.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Immersive virtual reality gamified cognitive activities
What this could lead to
If it works, this could offer a more engaging way to help people with brain injuries improve their attention and focus.
What could go wrong
This is an early-stage study with only 135 participants, so results may not apply to everyone. The benefits of VR over standard exercises are still unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 135 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2023

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Time from stroke onset \< 1 month * Objective pathological performance on at least one standardized test or subtest on attention during standard neuropsychological evaluation * Brain injury documented by routine neuroradiological examination (computed tomography or magnetic resonance imaging scan) * Able to give informed consent as documented by signature * Age \>= 18 years old Exclusion Criteria: * Epilepsy * Inability or contraindications to undergo the investigated intervention * Major psychiatric co-morbidity * Major neurocognitive deficits (e.g. dementia) * Incapacity to discriminate colors * General cognitive state preventing to understand and perform the tasks * Decision to not be informed of incidental findings

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Attention disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder Cognition Disorders stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Attention disorder Stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Lausanne Hospitals

    RECRUITING

    Lausanne, 1015, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.